Original Publication Date: 1 December, 2015
Publication / Source: Lung Cancer Management
Authors: Greg Durm & Nasser Hanna
Despite a number of recent breakthroughs in the treatment of metastatic NSCLC, the management of patients with stage III disease remains a challenge. The standard of care remains concurrent chemoradiation, and though a number of treatment strategies have been studied, no novel approach has clearly shown a consistent benefit.